ADRB3 and metabolic dysfunction-associated steatotic liver disease: Our results suggest that in combination with the strict weight control (e.g., aimed at achieving a BMI of <23 kg/m2 in Japanese individuals), ADRB3 rs4994 polymorphism genotyping may provide a useful information to reduce the risk of developing NAFLD in individuals with the C/C genotype.